Joyner DE, Trang SH, Damron TA, Aboulafia AJ, Cummings JE, Randall RL. (2009). Desmoid cell motility is induced in vitro by rhEGF. J Orthop Res, 27:1258-1262.

Trang SH, Joyner DE, Damron TA, Aboulafia AJ, Randall RL. (2009). Potential for functional redundancy in EGF and TGF? signaling in desmoid cells: a cDNA microarray analysis. Clin Orthop Relat Res. (in press).

Joyner DE, Trang SH, Aboulafia AJ, Damron TA, Randall RL. (2009). FAP-associated Desmoid Invasiveness Correlates with in vitro Resistance to Doxorubicin. Fam Cancer. (in press).

Joyner DE, Aboulafia AJ, Damron TA, Randall RL. (2008). Fas Death Pathway in Sarcomas Responds to Epidermal Growth Factor Transcription. Clin Orthop Relat Res. (in press).

Joyner DE, Damron TA, Aboulafia AJ, Randall RL. (2007). Oncogene Coexpression in Mesenchymal Neoplasia Correlates with EGF transcription. Clin Orthop Relat Res, 459, 14-21.

Joyner DE, Damron TA, Aboulafia A, Bokor W, Bastar JD, Randall RL. (2006). Heterogeneous expression of melanoma antigen (hMAGE) mRNA in mesenchymal neoplasia. Tissue Antigens, 68(1), 19-27.

Joyner DE, Bastar JD, Randall RL. (2006). Doxorubicin induces cell senescence preferentially over apoptosis in the FU-SY-1 synovial sarcoma cell line. J Orthop Res, 24(6), 1163-9.

Joyner DE, Albritton KH, Bastar JD, Randall RL. (2006). G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line. J Orthop Res, 24(3), 474-80.

Randall RL, Damron TA, Coffin CM, Bastar JD, Joyner DE. (2005). Transit tumor retrieval preserves RNA fidelity and obviates snap-freezing. Clin Orthop Relat Res, 438, 149-57.

Joyner DE, Albritton KH, Bastar J, Randall RL.(in review). G3139 Antisense oligonucleotide directed against anti-apoptotic Bcl-2 enhances doxorubicin dytotoxicity in the FU-SY-1 synovial sarcoma cell line. J. Ortho. Res.

Randall RL, Damron T, Coffin CM, Bastar J, Joyner DE. 2005. Clinical retrieval and inter-institutional transport of genomic message transcripts for expression analyses: an assessment of molecular integrity. Clin. Ortho. Related Res.

Joyner DE, Wade ML, Szabo A, Bastar J,Coffin CM, Albritton KH, Bernard P, Randall RL. 2005. Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo. J. Cancer Res. Clinical Oncol. 131: 137-146.

Randall RL, Lessnick SL, Johnson B, Joyner DE. 2004. Molecular biology of sarcomas: update-the cell cycle paradigm. Curr. Opinions Ortho. 15: 456-467.

Randall RL, Wade M, Albritton KH, Joyner DE. 2003. Retrieval yield of total and messenger RNA in mesenchymal tissue ex vivo. Clinical Orthopedics and Related Research 415: 59-63.

Randall RL, Wade M, Coffin CM, Albritton KH, Joyner DE. 2003. Validation of cDNA microarray analysis to distinguish tumor type ex vivo. Clinical Orthopedics and Related Research 415: S110-S119.